What are the comparative benefits and harms of using CBT-I versus benzodiazepines for the treatment of insomnia?
Abstract
CBT-I is recommended as the first-line treatment for insomnia due to its long-term efficacy and safety, while the short-term benefits of benzodiazepines are limited by potential risks including dependence and cognitive impairment.
Fields of Study & Subjects
Sleep and related disorders
Anxiety
Depression
Psychometrics
Treatment
Cognitive Processes
Obstructive Sleep Apnea Research
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 12 February 2026
- Language
- EN